According to Health Canada (via FOI), this recall involved a device in Canada that was produced by MEDTRONIC OF CANADA LTD..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Risk Class
  • Event Initiated Date
  • Event Country
  • Event Source
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Medtronic is mailing a safety notification to physicians associated with the synchromed infusion pump. this notification provides important information on medtronic neuromodulation's continuing efforts to investigate and communicate the impact of unapproved drugs on the performance of the synchromed infusion pump system. it includes information on motor gear corrosion which has been identified as the primary contributor to pump motor stall in the synchromed ii and synchromed el pumps. this communication is intended to reinforce with healthcare professionals the importance of following the labeling with respect to the use of indicated drugs. all active implanting or managing physicians associated with the synchromed drug infusion pump are in scope for this communication.


  • Model / Serial
    Model Catalog: 8637 (Lot serial: All Lots); Model Catalog: 8626L (Lot serial: All Lots); Model Catalog: 8627L (Lot serial: All Lots); Model Catalog: 8627 (Lot serial: All Lots); Model Catalog: 8626 (Lot serial: All Lots)
  • Product Classification
  • Product Description
    SynchroMedr II Implantable Drug Infusion Pump
  • Manufacturer


  • Manufacturer Address
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source